The only FDA-approved GHRH analog that targets dangerous visceral fat surrounding your organs — clinically proven to reduce belly fat by 18% and liver fat by 37% in Phase 3 trials, while preserving lean muscle and supporting cognitive function through your body's own growth hormone pathway.
Tesamorelin
2mg/mL (10mg)
$299.00/month
Quantity
- Licensed Physicians
- Free Shipping
- Cancel Anytime
- HSA/FSA Eligible
$299.00/mo per unit. Cancel anytime — no commitments.
As Seen In
The Science
What is Tesamorelin?
Tesamorelin is a 44-amino-acid synthetic analog of Growth Hormone-Releasing Hormone (GHRH) — the same signaling molecule your hypothalamus naturally produces. When injected subcutaneously, it binds to GHRH receptors on your pituitary gland, triggering a natural pulse of growth hormone. This GH elevation increases Insulin-like Growth Factor 1 (IGF-1), which drives lipolysis — the breakdown of stored fat — particularly in visceral adipose tissue surrounding your organs. It is the only GHRH analog with FDA approval, backed by Phase 3 clinical trials in over 400 patients.
Unlike synthetic HGH injections that bypass your body's regulatory system, Tesamorelin preserves your natural somatostatin feedback loop. This means your body maintains control over growth hormone levels, dramatically reducing the risk of side effects like insulin resistance, organ enlargement, and hormonal imbalance. The result is targeted fat reduction where it matters most — around your organs — while supporting lean muscle, liver health, and cognitive function.
18%
Visceral fat reduction in 26-week clinical trials
FDA
Only FDA-approved GHRH analog (since 2010)
37%
Liver fat reduction in NAFLD patients
404
Patients in Phase 3 clinical trials
Phase 3 clinical trial data; Egrifta (tesamorelin) FDA approval, November 2010. Hepatic fat reduction data from NAFLD clinical studies.
Why It Matters
Why Tesamorelin is different.
Tesamorelin is widely regarded as the most potent GHRH analog available. Its modified N-terminal structure (trans-3-hexenoic acid group) makes it significantly more resistant to enzymatic degradation than older peptides like Sermorelin, delivering stronger and more consistent growth hormone pulses. In clinical trials, it demonstrated an 18% reduction in visceral fat over 26 weeks — results no other peptide has matched in FDA-reviewed data.
Administered once daily via a simple subcutaneous injection at bedtime, Tesamorelin works with your body's natural circadian GH rhythm. Its short half-life (26-38 minutes) mimics the pulsatile GH release your body produces naturally, avoiding the sustained supraphysiological levels that make synthetic HGH risky. One injection, once a day — that's it.
Compare Treatments
Tesamorelin vs. Other Options
| Recommended Tesamorelin | Synthetic HGH | Sermorelin | |
|---|---|---|---|
| Mechanism | Stimulates natural GH production | Replaces GH entirely | Stimulates natural GH |
| FDA-Approved for Fat Reduction | |||
| Visceral Fat Targeting | Partial | Minimal | |
| Preserves Feedback Loop | |||
| Liver Fat Reduction | Not studied | ||
| Cognitive Benefits | |||
| Risk of Insulin Resistance | Low | High | Low |
| Clinically Studied (Phase 3) | |||
| Administration | 1x daily injection | Daily injection | 1-2x daily injection |
| Monthly Cost | $$$ | $$$$ | $$ |
Benefits of Tesamorelin Therapy
Targeted Visceral Fat Loss
Specifically breaks down the dangerous fat surrounding your organs, where diet and exercise alone often fail.
Lean Muscle Preservation
Stimulates growth hormone to maintain and build lean tissue while you lose fat, avoiding the muscle wasting common with caloric restriction.
Liver Health & Metabolic Reset
Clinically shown to reduce hepatic fat by approximately 37%, improving fatty liver markers and overall metabolic function.
Cognitive Enhancement
Favorable effects on memory and executive function demonstrated in clinical trials, supporting mental clarity as you age.
Cardiovascular Protection
Improves lipid profiles, reduces triglycerides, and lowers inflammatory markers associated with heart disease risk.
Natural & Safe Stimulation
Works with your body's own feedback mechanisms rather than overriding them, maintaining physiological balance while delivering results.
Is It Right For You?
Who Tesamorelin Is For
Stubborn Belly Fat Despite Diet & Exercise
You work out, eat well, but visceral fat around your midsection won't budge. Tesamorelin targets this specific fat depot that resists conventional approaches.
Age-Related GH Decline (35+)
Growth hormone production drops approximately 14% per decade after age 30. If you're experiencing increased abdominal fat, reduced muscle tone, slower recovery, and declining energy, your GH levels may be the underlying cause.
Metabolic & Liver Health Concerns
Elevated liver enzymes, fatty liver diagnosis, poor lipid panels, or pre-diabetic markers. Tesamorelin addresses the visceral fat that drives metabolic dysfunction at its source.
Not sure if Tesamorelin is right for you? Our licensed physicians will evaluate your health history, review bloodwork, and help determine the best treatment plan during your consultation.
The Process
How It Works
01
Complete Online Assessment
Answer a brief health questionnaire about your symptoms, medical history, and wellness goals.
02
Physician Review & Prescription
A licensed physician reviews your assessment and bloodwork. If appropriate, they prescribe a personalized Tesamorelin protocol.
03
Delivered to Your Door
Your prescription is filled by our FDA-registered pharmacy and shipped directly to you with everything you need.
04
Monthly Check-ins
Regular follow-ups with your physician to monitor progress, adjust dosing, and optimize your results.
What Our Patients Say
"I'd been training 5 days a week for years and couldn't get rid of the belly. After 8 weeks on Tesamorelin, I lost 2 inches off my waist and my bloodwork showed my triglycerides dropped significantly. My doctor was impressed."
Visceral fat down
— M.R., 47, using Tesamorelin for 3 months
"The brain fog I'd been living with for years lifted within the first month. I'm sleeping deeper, recovering faster from workouts, and my midsection is finally leaning out. This is what I thought HGH would feel like but without the risks."
Mental clarity restored
— K.T., 52, using Tesamorelin for 4 months
"My liver ultrasound showed fatty liver last year. After 5 months on Tesamorelin my follow-up showed marked improvement. I also dropped 15 pounds of pure abdominal fat. My gastroenterologist asked what I changed."
Liver health improved
— D.S., 44, using Tesamorelin for 5 months
Your Medical Team
Dr. Sarah Chen, MD
Board-Certified Endocrinologist
Specializes in metabolic disorders and longevity medicine with 12+ years of clinical experience.
Dr. James Miller, DO
Internal Medicine & Peptide Therapy
Fellowship-trained in regenerative medicine with expertise in peptide therapy and hormone optimization protocols.
Dr. Priya Patel, MD
Family Medicine & Preventive Care
Focused on patient-centered care and preventive health protocols for over a decade.
Quality & Safety
FDA-Registered Compounding Pharmacy
Every order is filled by a licensed, FDA-registered 503B compounding pharmacy that meets the highest standards of quality, potency, and sterility.
Our pharmacy partners maintain full accreditation from leading regulatory bodies, ensuring your medication is safe, pure, and prepared under strict quality controls.
The Mars Guarantee
If you're not satisfied within 30 days of your purchase, we'll issue a full refund — no questions asked. We stand behind the quality and efficacy of every product we sell.
Get Started Risk-FreeFrequently Asked Questions
Tesamorelin is a synthetic 44-amino-acid peptide analog of your body's Growth Hormone-Releasing Hormone (GHRH). It binds to receptors on your pituitary gland, triggering natural growth hormone release. This elevated GH increases IGF-1, which drives the breakdown of stored fat — particularly visceral fat surrounding your organs. It is the only GHRH analog with FDA approval.
Growth hormone and IGF-1 preferentially target visceral adipose tissue (VAT) because these fat cells have a higher density of GH receptors and greater lipolytic sensitivity. In Phase 3 trials, patients saw an 18% reduction in visceral fat over 26 weeks, with results beginning as early as 2-4 weeks.
Yes. Clinical studies have demonstrated approximately 37% reduction in hepatic (liver) fat in patients with non-alcoholic fatty liver disease (NAFLD). By reducing visceral fat and improving lipid metabolism, Tesamorelin addresses one of the root causes of metabolic liver disease.
Clinical trial data shows favorable effects on cognition, including memory and executive function, in both adults with mild cognitive impairment and healthy older adults. The mechanism may involve increased neurotransmitter levels and improved cerebral blood flow from elevated growth hormone and IGF-1.
IGF-1 elevation is measurable via bloodwork within 2-4 weeks. Visible changes in abdominal circumference typically begin at 6-8 weeks. Maximum benefit in clinical trials was observed at 26 weeks (6 months). Most patients report improved sleep and energy within the first 2 weeks.
One subcutaneous injection daily, self-administered at home. The injection is given in the abdominal area using a small insulin-type needle. Best administered at bedtime on an empty stomach (90+ minutes after your last meal) to align with your body's natural nighttime growth hormone pulse.
The most common side effect is mild injection site reactions (redness, swelling) occurring in approximately 24% of patients. Other possible effects include temporary joint discomfort, mild water retention, and tingling in extremities. Importantly, Tesamorelin does NOT significantly elevate blood glucose in most patients — a critical safety advantage over synthetic HGH.
Yes. Tesamorelin was FDA-approved in November 2010 under the brand name Egrifta (now Egrifta SV) for the treatment of HIV-associated lipodystrophy. Its use for general visceral fat reduction and anti-aging is prescribed off-label at physician discretion — a common and legal practice in medicine.
Synthetic HGH replaces your body's growth hormone entirely, bypassing natural regulation and increasing risk of insulin resistance, organ growth, and hormonal imbalance. Tesamorelin stimulates your own GH production while preserving your somatostatin feedback loop — your body maintains control, making it dramatically safer for long-term use.
Tesamorelin is not appropriate for pregnant or breastfeeding women, anyone with active cancer or malignancy, pituitary gland disorders, or known hypersensitivity to tesamorelin or mannitol. Your prescribing physician will review your full medical history before approval.
Yes. Tesamorelin is commonly stacked with Ipamorelin for synergistic GH release. It can complement GLP-1 medications for comprehensive body composition management, or BPC-157 for enhanced recovery. Your physician will design a protocol based on your goals and health profile.
Both are GHRH analogs, but Tesamorelin is more potent due to its modified N-terminal structure that resists enzymatic breakdown. Tesamorelin has FDA approval and Phase 3 trial data for visceral fat reduction; Sermorelin does not. Tesamorelin consistently delivers stronger GH pulses and more targeted fat loss results.
Unreconstituted vials should be stored refrigerated at 36-46°F (2-8°C). Once reconstituted with bacteriostatic water, use within 21 days and keep refrigerated. Do not freeze. Protect from light.
Clinical data shows partial fat regain after discontinuation, as the underlying age-related GH decline resumes. Many patients use cycling protocols (2-3 months on, 1 month off) to maintain results while allowing natural axis recovery. Your physician will recommend the optimal approach.
